For Healthcare Providers
Resources for healthcare providers and prescribers on managing drug shortages, helping patients find medications, and savings programs.
826 articles
Buprenorphine/Naloxone Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Buprenorphine/Naloxone supply in 2026: prescribing implications, availability, cost, and tools to support patient access.
Treximet Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Treximet availability in 2026: prescribing implications, cost barriers, alternatives, and tools to help your patients.
Ortho Tri-Cyclen 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Ortho Tri-Cyclen 28 Day availability in 2026: brand discontinuation, generic supply, prescribing strategies, and patient tools.
Eohilia shortage: What providers and prescribers need to know in 2026
Provider-focused Eohilia shortage and access update for 2026. Prior authorization strategies, alternative therapies, and tools to help your EoE patients.
28,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Apremilast Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Apremilast (Otezla) access challenges in 2026. Covers availability, prior authorization, cost barriers, alternatives, and tools to help patients.
Dronabinol Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on Dronabinol availability in 2026. Shortage history, prescribing implications, cost considerations, and clinical tools.
Merilog Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Merilog (insulin aspart-szjj) availability for providers. Covers shortage status, prescribing considerations, alternatives, and patient access tools.
Ketamine Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on the Ketamine shortage in 2026: supply timeline, prescribing implications, availability by formulation, and tools to help patients.
Dymista Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Dymista availability in 2026. Current supply status, prescribing implications, cost data, and tools to help your patients.
Breo Ellipta Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on Breo Ellipta availability in 2026 — covering supply status, prescribing implications, alternatives, and patient access tools.
Duavee Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the Duavee shortage in 2026. Availability timeline, prescribing implications, alternatives, cost considerations, and patient access tools.
Claravis Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on the Claravis (Isotretinoin) shortage in 2026 for dermatologists and prescribers — timeline, alternatives, and tools for patient access.